Healthcare Social Media and Updates
Healthcare Social Media and Updates
Healthcare Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
I've known @dmgorenstein for 2 decades and have always found him to be extraordinarily thoughtful – not afraid to ask tough questions and to grapple with nuance and, yes, tradeoffs. It was great to chat with him on his @tradeoffspod about healthcare AI. https://t.co/uByY2oPwHn
Patent Fights, GLP-1 Turf Wars, and the FDA Tightens the Screws | Ep. 952 https://t.co/v0fulR3NfB https://t.co/9gGdkAVvlv
A revenue-cycle nurse cut denials by 60% in 1 month using agentic AI. See how in the new article from Anshar AI 👉 https://t.co/mKAaugRe28 Meet them at #HIMSS26 or book a private workflow session. #AnsharAI #HITSM
There's a lot you can learn about sleep. Like 83% hadn't heard of DORAs. https://t.co/2lV3Fw6cwg https://t.co/IWRTdPTMOL
One of the most impressive advances we've ever seen for some autoimmune diseases: cures https://t.co/OZDuq4Iooy
Fragmentomic liquid biopsy enables early breast cancer detection, molecular subtyping and lymph node assessment https://t.co/RC5rTrFO4l https://t.co/s0Z6lc7Jeb
"A series of WBC sessions improved carbohydrate metabolism and modulated adipokine and sirtuin profiles, with the most pronounced effects observed in individuals with elevated BMI. However, this effect generally may require a longer treatment series." The effect of whole-body cryostimulation treatments...
Ambient Temperature and Adult Obesity: Evidence from U.S. County-Level Panel Data "The results indicate that higher ambient temperatures are associated with higher adult obesity rates, even after accounting for correlated environmental conditions..." https://t.co/ewEuMdqr3O
Bright light therapy influences glymphatic system function in individuals with subthreshold depression: a randomized clinical trial Highlights 👇👨🏻⚕️” 🔘 Bright light therapy (BLT) influences glymphatic function in subthreshold depression. 🔘 BLT enhanced brain functional activity of the prefrontal cortex. 🔘 BLT links glymphatic system...
Bitter Compounds as Multifunctional Agents against Diabetes-associated Cognitive Dysfunction: Bridging Metabolic Regulation and Neuroprotection https://t.co/Xv3xItlP20
joked with my old cofounder about using the next 90 days to vibe replicate all the products and data tools that took us 3 years to build at our startup... I think i'll be done in 7. next up: AI agents...
A health system once celebrated our Health Tech partnership’s amazing results, and then walked away - all because of the most dangerous word in innovation: “grant-funded.” I've watched more grant-funded pilots quietly die than I care to count. The problem? A...
The future of U.S. medicine: 10 health care trends in 2026 https://t.co/Cp6QufTISs #Physician #Malpractice via @kevinmd
Artificial intelligence in clinical care: Shaping the HHS policy landscape https://t.co/XF7GFSav1j #Policy #PublicHealthPolicy via @kevinmd
Human Growth Hormone May Be Detrimental When Used to Accelerate Recovery from Acute Tendon-Bone Interface Injuries https://t.co/L4EOFMKjys
PEP protects against age-related inflammation, puts the brake on the aging process in mice, high levels in humans correlate with low inflammation So what is PEP, you ask? phosphoenolpyruvate, from glucose metabolism, a, master regulator, blocks cGAS-STING https://t.co/glMvaHSjOq https://t.co/MSVMBJbHm4
More EHR vendors are realizing: Medication management isn’t a side feature—it’s a specialty. Why partnering can unlock more innovation than building it all in-house: https://t.co/SfXzUvDcRb @DrFirst #medicationmanagement #HITSM
Roche, Zealand shares fall on ‘undifferentiated’ obesity drug results https://t.co/5pSR2vcHBD by @Lilah_Alvarado $RHHBY $ZEAL $LLY $NVO #obesity
Servier to build cancer drug pipeline with $2.5B purchase of Day One https://t.co/aH0z8jt9tr by @realJacobBell $DAWN #biotech
AWS launches Amazon Connect Health: to automate administrative tasks like scheduling and documentation with AI... https://t.co/DDCqpspUyd
Gee, who could this "senior FDA official" be? It's a head scratcher. But he might tell Vinay Prasad that thinly veiled attacks against, oh, UniQure, and going off on advisory councils is a great way of keeping the political pot...
I taught medical students that insulin resistance is a mystery. It's not. A new study in Science Advances just identified the molecular trigger - mitochondrial oxidative stress. Here's what they found: > Lipid overload floods mitochondria with reactive oxygen species > This blocks GLUT4...
The Hidden Blood Test Your Doctor Isn"t Ordering Why Fasting Insulin Matters More Than Glucose https://youtu.be/ylkO3ETjEIE
New from me on $QURE and FDA. Free, no paywall. The FDA, urged to avoid controversy, creates a new headache with attack against UniQure Anonymous diatribe from a senior official plunges agency back into headlines https://t.co/ceDE0TXjdI
As a medical school professor, I tell my students: disease doesn't start in your organs. It starts in your environment. A new Nature study just proved it - your zip code literally rewires your gut microbiome. Researchers studied 1,390 people and found: >...
Most healthcare AI founders think they’re selling innovation. They’re not. They’re being screened for friction. Implementation drag. IT burden. Workflow disruption. Hidden costs. Governance risk. That’s how buyers actually evaluate healthcare AI. We’re building around that reality inside WomenInGenAI’s AI in Healthcare space. Reply “healthcare” and I’ll send the link.
A Master Class on Sleep, with plenty of practical tips Eric Topol with Guest Professor Yo-El Ju https://t.co/sKY9e7Tinq https://t.co/Gofntnw02o
Association between dietary fiber intake and bone mineral density: a systematic review and meta-analysis of observational studies https://t.co/Q3yGX1Xd8j
HS-20093, a B7-H3-targeted antibody-drug conjugate in lung cancer: Results from the ARTEMIS-001 phase 1a/b trial https://t.co/Jr90iovVeo https://t.co/Nl2WkprjU3
The job market is weakening as work requirements are poised to go into effect for Medicaid and ACA premium assistance is decreasing.
$DAWN acquisition by Servier for $2.5bn is quite the ending for Ojemda. Who remembers this RAF inhibitor's bizarre & convoluted history? $BIIB $TAK https://t.co/uD5drO9ymr
Advance in neuroprotective effects of proanthocyanidins (PCs): Structure, absorption, bioactivities, mechanism, and perspectives https://t.co/AMfxcjo4m6 https://t.co/oTMCLW0CKL
@HeyEpic's Workshop category is down to 3 vendors, as @PressGaney just got moved to Toolbox, and the rest are likely to follow. So what does it actually look like to partner with Epic in 2026? I mapped it out (from...
A narrative review on the therapeutic potential of stem cells in neurodegenerative diseases: advances, insights, and challenges 👉"Stem cell therapy offers regenerative potential for neurodegenerative diseases. 👉Mesenchymal stem cells (MSCs), induced pluripotent stem cells, and neural stem cells show promise through neuroprotection...
Especially after the recent disappointing regulatory update regarding $QURE AMT-130 clinical candidate for treating Huntington disease and the FDA refusal to move forward 🧵👇- here is an excellent Infograph by the BBC which explains how exactly the mechanism of @uniQure_NV’s...
In early 2026, The Lancet published the TRICORDER study, a pragmatic, real-world evaluation involving 205 primary care practices and about 1.5 million patients, proving that digital stethoscopes have a place in care. For clinicians seeking practice-ready digital transformation, this device could...
The AI tool I called “best in class” just got dethroned - in three months. So when health systems go all-in on one AI vendor, is that a BIG mistake? I was loyal to ChatGPT. Then I became Gemini-pilled. Recently my...
So I've read a few long essays on how abusive pharmaceutical benefit managers and group purchasing organizations are, and they all make a strong case. And then I look at the companies that own PBMs, and their margins are a)...
Today, @DrJessePines, writing in @Forbes, covered the NOHARM benchmark — one of the most rigorous evaluations of clinical AI to date. 100 real medical cases across 10 specialties, 12,747 specialist annotations on beneficial and harmful medical actions, and 31 AI systems rigorously...
Indices of Sleep Health Are Associated With Timing and Duration of Eating in Young Adults - Journal of the Academy of Nutrition and Dietetics https://t.co/RztLzXUScr
Ribosomes as Drug Targets. The Quiet Rewrite of Psychiatry and Beyond. | Ep. 950 https://t.co/gKlWpzO1Ci https://t.co/ImGOmUVrSO
What good things is AI doing? Here's 10 things my AI agents found here on X that are examples of good things AI has done for humans. +++++ 1. "ChatGPT saved my life" — grocery store conversation about an ultra-rare diagnosis "Doctors...
2026 aging/longevity conferences mostly have announced dates now. A few date just announced. Here's what the schedule looks like at the moment. Next up is Longevity Global's Longevity Innovation Forum in San Diego next week. https://t.co/mIDmfQD38H I'll be there & speaking. https://t.co/4mRLXJmGgg
When it comes to GLP‑1s, many employers feel stuck between “do nothing” and “all‑in coverage.” That’s not a great set of choices, especially when they want to find a way to say yes. I’m excited that @OmadaHealth is adding a...
Neuropathic pain affects 7-10% of all people globally. New 🐁 study finds resveratrol alleviates neuropathic pain associated with restoration of mitochondrial dynamics 👏 https://t.co/zJ8LvwZ9UP https://t.co/hdCK7UgqBj
Things that I think are diabolical: 1) Being charged per page for your *electronic* medical records 2) Being charged for your doctor to complete a necessary form 3) no validation for emergency room parking Yes, there are far more diabolical things...
Ambient scribe → codes → claims → payments. AI doesn’t respect org charts. NextGen explains why fragmented workflows are becoming a liability. 👀 🔗 https://t.co/557h8ofHZ0 @NextGen #AmbulatoryEHR #HITSM
Will we give a shot of protective, self-amplifying RNA in patients with a heart attack in the future? @ScienceMagazine an intriguing innovation https://t.co/FcJme1ElyU https://t.co/lABFRkR3qg
For Second Opinion, we had a long sit-down with Medicare chief Chris Klomp. We covered: -- MA rates staying flat -- Steps to thwart info blocking -- Bringing AI into healthcare outside of the fee schedule -- The ACCESS model & more https://t.co/dZEzyUtWbz https://t.co/PGO80SlZ9T
When cancer niches are rapidly changing they create both a vacuum of indecision and fresh opportunities for smart players. Here we explore bladder cancer and look at where the field is headed... https://t.co/cf93Qb8dhe https://t.co/fx5V1MVwYN
